Combined Power to Change the Game: RYBREVANT® + LAZCLUZE™ in First-Line Treatment of EGFR+* Locally Advanced or mNSCLC ~ Thursday, 10/24/24

Click here to register and learn more!

Presented by:

Mark Socinski, MD

Executive Medical Director

AdventHealth Cancer Institute, Orlando, FL

Location:

Grill 23 and Bar,

161 Berkeley Street,

Boston, Massachusetts 02116

(617) 542-2255

cp-417857v1-IN PERSON Invite - Rybrevant Branded (Print)-Merged (1).PDF

Download PDF • 2.06MB